EUVIMEDEUVIMED entdecken
Crossref

Exploring the biological mechanism of Wendan decoction against COPD based on UHPLC-DAD: experimental validation and molecular docking

Qi Yu, Guoan Zhao, Xuanyu Fu, Yuyang Chen, Shutong Chen, Ying Lyu, Shan Ren, Song Lin, Yan Lin, Tianyang Wang

New Journal of Chemistry · 2026 · 50 (14) · 5934-5946

DOI: 10.1039/d5nj04982b ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Journal of Chemistry, 2026. Verfasst von Qi Yu und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wendan decoction alleviates COPD by inhibiting pulmonary inflammation via the NF-κB-NLRP3/AA signaling pathway.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yu, Q., Zhao, G., Fu, X., Chen, Y., Chen, S., Lyu, Y., Ren, S., Lin, S., Lin, Y., & Wang, T. (2026). Exploring the biological mechanism of Wendan decoction against COPD based on UHPLC-DAD: experimental validation and molecular docking. New Journal of Chemistry, 50(14), 5934-5946. https://doi.org/10.1039/d5nj04982b

Vancouver

Yu Q, Zhao G, Fu X, Chen Y, Chen S, Lyu Y, et al. Exploring the biological mechanism of Wendan decoction against COPD based on UHPLC-DAD: experimental validation and molecular docking. New Journal of Chemistry. 2026;50(14):5934-5946. doi:10.1039/d5nj04982b

BibTeX
@article{Yu2026,
  author = {Yu, Qi and Zhao, Guoan and Fu, Xuanyu and Chen, Yuyang and Chen, Shutong and Lyu, Ying and Ren, Shan and Lin, Song and Lin, Yan and Wang, Tianyang},
  title = {Exploring the biological mechanism of Wendan decoction against COPD based on UHPLC-DAD: experimental validation and molecular docking},
  journal = {New Journal of Chemistry},
  year = {2026},
  volume = {50},
  number = {14},
  pages = {5934--5946},
  doi = {10.1039/d5nj04982b}
}
Kostenlos starten →